- Home
- BWMX vs GOSS Comparison
BWMX vs GOSS Comparison
Compare BWMX & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMX
- GOSS
- Stock Information
- Founded
- BWMX 1995
- GOSS 2015
- Country
- BWMX Mexico
- GOSS United States
- Employees
- BWMX N/A
- GOSS N/A
- Industry
- BWMX Catalog/Specialty Distribution
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- BWMX Consumer Discretionary
- GOSS Health Care
- Exchange
- BWMX Nasdaq
- GOSS Nasdaq
- Market Cap
- BWMX 495.6M
- GOSS 347.8M
- IPO Year
- BWMX N/A
- GOSS 2019
- Fundamental
- Price
- BWMX $13.29
- GOSS $2.47
- Analyst Decision
- BWMX Strong Buy
- GOSS Strong Buy
- Analyst Count
- BWMX 1
- GOSS 4
- Target Price
- BWMX $22.50
- GOSS $8.50
- AVG Volume (30 Days)
- BWMX 55.5K
- GOSS 3.1M
- Earning Date
- BWMX 10-23-2025
- GOSS 08-05-2025
- Dividend Yield
- BWMX 10.75%
- GOSS N/A
- EPS Growth
- BWMX N/A
- GOSS N/A
- EPS
- BWMX 0.84
- GOSS N/A
- Revenue
- BWMX $751,432,052.00
- GOSS $40,237,000.00
- Revenue This Year
- BWMX $6.54
- GOSS N/A
- Revenue Next Year
- BWMX $6.09
- GOSS $30.65
- P/E Ratio
- BWMX $15.88
- GOSS N/A
- Revenue Growth
- BWMX 4.83
- GOSS N/A
- 52 Week Low
- BWMX $7.00
- GOSS $0.66
- 52 Week High
- BWMX $14.46
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- BWMX 62.09
- GOSS 68.08
- Support Level
- BWMX $13.06
- GOSS $2.38
- Resistance Level
- BWMX $13.50
- GOSS $2.65
- Average True Range (ATR)
- BWMX 0.45
- GOSS 0.15
- MACD
- BWMX -0.13
- GOSS 0.03
- Stochastic Oscillator
- BWMX 66.64
- GOSS 76.67
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.